Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 347

1.

Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.

Elias J, van Dongen IM, Råmunddal T, Laanmets P, Eriksen E, Meuwissen M, Michels HR, Bax M, Ioanes D, Suttorp MJ, Strauss BH, Barbato E, Marques KM, Claessen BEPM, Hirsch A, van der Schaaf RJ, Tijssen JGP, Henriques JPS, Hoebers LP; EXPLORE investigators.

Heart. 2018 Feb 20. pii: heartjnl-2017-312698. doi: 10.1136/heartjnl-2017-312698. [Epub ahead of print]

PMID:
29463612
2.

First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm.

Zivelonghi C, van Kuijk JP, Nijenhuis V, Poletti E, Suttorp MJ, van der Heyden JAS, Eefting FD, Rensing BJ, Ten Berg JM, Azzalini L, van den Brink FS, Ribichini F, Colombo A, Henriques JPS, Agostoni P.

Catheter Cardiovasc Interv. 2018 Feb 7. doi: 10.1002/ccd.27539. [Epub ahead of print]

PMID:
29411523
3.

Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood.

Toepfner N, Herold C, Otto O, Rosendahl P, Jacobi A, Kräter M, Stächele J, Menschner L, Herbig M, Ciuffreda L, Ranford-Cartwright L, Grzybek M, Coskun Ü, Reithuber E, Garriss G, Mellroth P, Henriques-Normark B, Tregay N, Suttorp M, Bornhäuser M, Chilvers ER, Berner R, Guck J.

Elife. 2018 Jan 13;7. pii: e29213. doi: 10.7554/eLife.29213.

4.

Veno-arterial extracorporeal membrane oxygenation in addition to primary PCI in patients presenting with ST-elevation myocardial infarction.

van den Brink FS, Magan AD, Noordzij PG, Zivelonghi C, Agostoni P, Eefting FD, Ten Berg JM, Suttorp MJ, Rensing BR, van Kuijk JP, Klein P, Scholten E, van der Heyden JAS.

Neth Heart J. 2018 Feb;26(2):76-84. doi: 10.1007/s12471-017-1068-y.

5.

Serum Interleukin-6 and CCL11/Eotaxin May Be Suitable Biomarkers for the Diagnosis of Chronic Nonbacterial Osteomyelitis.

Hofmann SR, Böttger F, Range U, Lück C, Morbach H, Girschick HJ, Suttorp M, Hedrich CM.

Front Pediatr. 2017 Dec 1;5:256. doi: 10.3389/fped.2017.00256. eCollection 2017.

6.

Percutaneous closure of a patent foramen ovale after cryptogenic stroke.

Snijder RJR, Suttorp MJ, Ten Berg JM, Post MC.

Neth Heart J. 2018 Jan;26(1):5-12. doi: 10.1007/s12471-017-1063-3. Review.

7.

Off‑target effect of imatinib and nilotinib on human vitamin D3 metabolism.

Kroschwald L, Suttorp M, Tauer JT, Zimmermann N, Günther C, Bauer A.

Mol Med Rep. 2018 Jan;17(1):1382-1388. doi: 10.3892/mmr.2017.7952. Epub 2017 Nov 3.

PMID:
29115640
8.

Pharmacology and pharmacokinetics of imatinib in pediatric patients.

Suttorp M, Bornhäuser M, Metzler M, Millot F, Schleyer E.

Expert Rev Clin Pharmacol. 2018 Mar;11(3):219-231. doi: 10.1080/17512433.2018.1398644. Epub 2017 Nov 6.

PMID:
29076384
9.

Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.

Yamaji K, Brugaletta S, Sabaté M, Iñiguez A, Jensen LO, Cequier A, Hofma SH, Christiansen EH, Suttorp M, van Es GA, Sotomi Y, Onuma Y, Serruys PW, Windecker S, Räber L.

JACC Cardiovasc Interv. 2017 Sep 25;10(18):1867-1877. doi: 10.1016/j.jcin.2017.07.035.

PMID:
28935079
10.

Feasibility of multiplane microtransoesophageal echocardiographic guidance in structural heart disease transcatheter interventions in adults.

Nijenhuis VJ, Alipour A, Wunderlich NC, Rensing BJWM, Gijsbers G, Ten Berg JM, Suttorp MJ, Boersma LVA, van der Heyden JAS, Swaans MJ.

Neth Heart J. 2017 Dec;25(12):669-674. doi: 10.1007/s12471-017-1036-6.

11.

Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents.

Millot F, Guilhot J, Suttorp M, Güneş AM, Sedlacek P, De Bont E, Li CK, Kalwak K, Lausen B, Culic S, Dworzak M, Kaiserova E, De Moerloose B, Roula F, Biondi A, Baruchel A.

Haematologica. 2017 Oct;102(10):1704-1708. doi: 10.3324/haematol.2017.170035. Epub 2017 Aug 24.

12.

The complexity of growth failure in children receiving tyrosine kinase inhibitor therapy for chronic myelogenous leukemia.

Samis J, Lee P, Zimmerman D, Suttorp M, Hijiya N.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26703. Epub 2017 Jul 11. No abstract available.

PMID:
28696050
13.

Treatment of high-grade osteoblastic osteosarcoma of the humerus in a 5-year-old boy with cystic fibrosis: A case report.

Okuda KV, Hammermann J, Lange BS, Fischer JC, Thielemann F, Knöfler R, Suttorp M.

Mol Clin Oncol. 2017 Jul;7(1):148-150. doi: 10.3892/mco.2017.1274. Epub 2017 May 29.

14.

A case of rivaroxaban-associated acute tubulointerstitial nephritis.

Monahan RC, Suttorp MM, Gabreëls BATF.

Neth J Med. 2017 May;75(4):169-171.

15.

Optical coherence tomography findings: insights from the "randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions" (PRISON IV) trial.

Teeuwen K, Spoormans EM, Bennett J, Dubois C, Desmet W, Ughi GJ, Belmans A, Kelder JC, Tijssen JGP, Agostoni P, Suttorp MJ, Adriaenssens T.

EuroIntervention. 2017 Aug 4;13(5):e522-e530. doi: 10.4244/EIJ-D-17-00261.

16.

Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents.

Millot F, Dupraz C, Guilhot J, Suttorp M, Brizard F, Leblanc T, Güneş AM, Sedlacek P, De Bont E, Li CK, Kalwak K, Lausen B, Culic S, Dworzak M, Kaiserova E, De Moerloose B, Roula F, Biondi A, Baruchel A, Guilhot F.

Cancer. 2017 Sep 15;123(18):3609-3616. doi: 10.1002/cncr.30767. Epub 2017 May 12.

PMID:
28497898
17.

Acute Cerebral Symptoms in a Child with Down Syndrome and Acute Leukemia - What has to be Considered?

Benecke N, Lange BS, Suttorp M, Hahn G, Knöfler R.

Klin Padiatr. 2017 May;229(3):177-179. doi: 10.1055/s-0042-124665. Epub 2017 Apr 4. No abstract available.

PMID:
28376541
18.

Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone marrow fibrosis.

Hussein K, Stucki-Koch A, Göhring G, Kreipe H, Suttorp M.

Leukemia. 2017 Jul;31(7):1540-1546. doi: 10.1038/leu.2017.73. Epub 2017 Feb 27.

PMID:
28239144
19.

Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV Trial.

Teeuwen K, van der Schaaf RJ, Adriaenssens T, Koolen JJ, Smits PC, Henriques JP, Vermeersch PH, Tjon Joe Gin RM, Schölzel BE, Kelder JC, Tijssen JG, Agostoni P, Suttorp MJ.

JACC Cardiovasc Interv. 2017 Jan 23;10(2):133-143. doi: 10.1016/j.jcin.2016.10.017.

20.

Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy.

Proschmann R, Baldow C, Rothe T, Suttorp M, Thiede C, Tauer JT, Müller MC, Hochhaus A, Roeder I, Glauche I.

Haematologica. 2017 Feb;102(2):e39-e42. doi: 10.3324/haematol.2016.154138. Epub 2016 Nov 17. No abstract available.

21.

Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial.

Henriques JP, Hoebers LP, Råmunddal T, Laanmets P, Eriksen E, Bax M, Ioanes D, Suttorp MJ, Strauss BH, Barbato E, Nijveldt R, van Rossum AC, Marques KM, Elias J, van Dongen IM, Claessen BE, Tijssen JG, van der Schaaf RJ; EXPLORE Trial Investigators.

J Am Coll Cardiol. 2016 Oct 11;68(15):1622-1632. doi: 10.1016/j.jacc.2016.07.744.

22.

Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia.

Samis J, Lee P, Zimmerman D, Arceci RJ, Suttorp M, Hijiya N.

Pediatr Blood Cancer. 2016 Aug;63(8):1332-8. doi: 10.1002/pbc.26028. Epub 2016 Apr 21. Review.

PMID:
27100618
23.

Novel Mutation in the DKC1 Gene: Neonatal Hoyeraal-Hreidarsson Syndrome As a Rare Differential Diagnosis in Pontocerebellar Hypoplasia, Primary Microcephaly, and Progressive Bone Marrow Failure.

Dehmel M, Brenner S, Suttorp M, Hahn G, Schützle H, Dinger J, Di Donato N, Mackenroth L, von der Hagen M.

Neuropediatrics. 2016 Jun;47(3):182-6. doi: 10.1055/s-0036-1578799. Epub 2016 Mar 7.

PMID:
26951492
24.

Impact of percutaneous coronary intervention timing on 5-year outcome in patients with non-ST-segment elevation acute coronary syndromes. The 'wait a day' approach might be safer.

Oosterwerff EF, Fagel ND, Slagboom T, Tijssen JG, Herrman JP, Smits PC, Suttorp MJ, Ronner E, Laarman GJ, Patterson MS, Amoroso G, Vink MA, van der Schaaf RJ, Verheugt FW, Riezebos RK.

Neth Heart J. 2016 Mar;24(3):173-80. doi: 10.1007/s12471-016-0803-0.

25.

Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group.

Cseh AM, Niemeyer CM, Yoshimi A, Catala A, Frühwald MC, Hasle H, van den Heuvel-Eibrink MM, Lauten M, De Moerloose B, Smith OP, Bernig T, Gruhn B, Kulozik AE, Metzler M, Olcay L, Suttorp M, Furlan I, Strahm B, Flotho C.

Br J Haematol. 2016 Mar;172(6):930-6. doi: 10.1111/bjh.13915. Epub 2016 Jan 13.

PMID:
26766110
26.

Mechanical Stress Changes the Complex Interplay Between HO-1, Inflammation and Fibrosis, During Excisional Wound Repair.

Cremers NA, Suttorp M, Gerritsen MM, Wong RJ, van Run-van Breda C, van Dam GM, Brouwer KM, Kuijpers-Jagtman AM, Carels CE, Lundvig DM, Wagener FA.

Front Med (Lausanne). 2015 Dec 15;2:86. doi: 10.3389/fmed.2015.00086. eCollection 2015.

27.

Recurrent Myocardial Infarction After Primary Percutaneous Coronary Intervention in Multivessel Coronary Disease Is Primarily Related to Stent Failure: Post-Hoc Analysis of the PASSION Trial.

Vink MA, Vos NS, Dirksen MT, Suttorp MJ, Slagboom T, Patterson MS, Kiemeneij F, Laarman G.

J Interv Cardiol. 2015 Dec;28(6):523-30. doi: 10.1111/joic.12246.

PMID:
26643000
28.

Pediatric Colorectal Carcinoma is Associated With Excellent Outcome in the Context of Cancer Predisposition Syndromes.

Weber ML, Schneider DT, Offenmüller S, Kaatsch P, Einsiedel HG, Benesch M, Claviez A, Ebinger M, Kramm C, Kratz C, Lawlor J, Leuschner I, Merkel S, Metzler M, Nustede R, Petsch S, Seeger KH, Schlegel PG, Suttorp M, Zolk O, Brecht IB.

Pediatr Blood Cancer. 2016 Apr;63(4):611-7. doi: 10.1002/pbc.25839. Epub 2015 Nov 17.

PMID:
26575411
29.

Pediatric chronic myeloid leukemia is a unique disease that requires a different approach.

Hijiya N, Schultz KR, Metzler M, Millot F, Suttorp M.

Blood. 2016 Jan 28;127(4):392-9. doi: 10.1182/blood-2015-06-648667. Epub 2015 Oct 28.

30.

Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.

Sabaté M, Windecker S, Iñiguez A, Okkels-Jensen L, Cequier A, Brugaletta S, Hofma SH, Räber L, Christiansen EH, Suttorp M, Pilgrim T, Anne van Es G, Sotomi Y, García-García HM, Onuma Y, Serruys PW.

Eur Heart J. 2016 Jan 14;37(3):229-40. doi: 10.1093/eurheartj/ehv500. Epub 2015 Sep 23.

31.

Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials.

Wijns W, Suttorp MJ, Zagozdzon L, Morice MC, McClean D, Stella P, Donohoe D, Knape C, Ormiston J.

EuroIntervention. 2016 Jun 20;12(3):352-5. doi: 10.4244/EIJY15M09_14.

32.

Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study.

Räber L, Onuma Y, Brugaletta S, Garcia-Garcia HM, Backx B, Iñiguez A, Okkels Jensen L, Cequier-Fillat À, Pilgrim T, Christiansen EH, Hofma SH, Suttorp M, Serruys PW, Sabaté M, Windecker S.

EuroIntervention. 2016 Jul 20;12(4):482-9. doi: 10.4244/EIJY15M08_03.

33.

Treatment with high dose of erythropoiesis-stimulating agents and mortality: analysis with a sequential Cox approach and a marginal structural model.

Suttorp MM, Hoekstra T, Mittelman M, Ott I, Krediet RT, Dekker FW, Putter H.

Pharmacoepidemiol Drug Saf. 2015 Oct;24(10):1068-75. doi: 10.1002/pds.3855. Epub 2015 Aug 12.

PMID:
26265483
34.

Trends in haemoglobin, erythropoietin-stimulating agents and iron use in Swedish chronic kidney disease patients between 2008 and 2013.

Evans M, Suttorp MM, Bellocco R, Hoekstra T, Qureshi AR, Dekker FW, Carrero JJ.

Nephrol Dial Transplant. 2016 Apr;31(4):628-35. doi: 10.1093/ndt/gfv298. Epub 2015 Aug 4.

PMID:
26243782
35.

Impact of long-term exposure to the tyrosine kinase inhibitor imatinib on the skeleton of growing rats.

Tauer JT, Hofbauer LC, Jung R, Gerdes S, Glauche I, Erben RG, Suttorp M.

PLoS One. 2015 Jun 24;10(6):e0131192. doi: 10.1371/journal.pone.0131192. eCollection 2015.

36.

Initial experience with therapeutic geometric modification of the carotid bulb for true resistant hypertension.

Habib N, Mahmoodi BK, Bos WJ, Tromp SC, Suttorp MJ, Bates MC, Van der Heyden J.

EuroIntervention. 2015 May;11(1):117-20. doi: 10.4244/EIJV11I1A20.

37.

Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents.

Lehmberg K, Sprekels B, Nichols KE, Woessmann W, Müller I, Suttorp M, Bernig T, Beutel K, Bode SF, Kentouche K, Kolb R, Längler A, Minkov M, Schilling FH, Schmid I, Vieth S, Ehl S, Zur Stadt U, Janka GE.

Br J Haematol. 2015 Aug;170(4):539-49. doi: 10.1111/bjh.13462. Epub 2015 May 4.

PMID:
25940575
38.

Can prognostic scoring systems for chronic myeloid leukemia as established in adults be applied to pediatric patients?

Gurrea Salas D, Glauche I, Tauer JT, Thiede C, Suttorp M.

Ann Hematol. 2015 Aug;94(8):1363-71. doi: 10.1007/s00277-015-2367-2. Epub 2015 Apr 19.

PMID:
25894600
39.

Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group.

Cseh A, Niemeyer CM, Yoshimi A, Dworzak M, Hasle H, van den Heuvel-Eibrink MM, Locatelli F, Masetti R, Schmugge M, Groß-Wieltsch U, Candás A, Kulozik AE, Olcay L, Suttorp M, Furlan I, Strahm B, Flotho C.

Blood. 2015 Apr 2;125(14):2311-3. doi: 10.1182/blood-2015-01-619734. No abstract available.

40.

Percutaneous closure of secundum type atrial septal defects: More than 5-year follow-up.

Snijder RJ, Suttorp MJ, Berg JM, Post MC.

World J Cardiol. 2015 Mar 26;7(3):150-6. doi: 10.4330/wjc.v7.i3.150.

41.

A child with Li-Fraumeni syndrome: Modes to inactivate the second allele of TP53 in three different malignancies.

Schlegelberger B, Kreipe H, Lehmann U, Steinemann D, Ripperger T, Göhring G, Thomay K, Rump A, Di Donato N, Suttorp M.

Pediatr Blood Cancer. 2015 Aug;62(8):1481-4. doi: 10.1002/pbc.25486. Epub 2015 Mar 18.

PMID:
25787918
42.

TIDES-ACS Trial: comparison of titanium-nitride-oxide coated bio-active-stent to the drug (everolimus)-eluting stent in acute coronary syndrome. Study design and objectives.

Colkesen EB, Eefting FD, Rensing BJ, Suttorp MJ, Ten Berg JM, Karjalainen PP, Van Der Heyden JA.

Minerva Cardioangiol. 2015 Feb;63(1):21-9.

PMID:
25670057
43.

Managing children with chronic myeloid leukaemia--response to Baccarani.

Millot F, Suttorp M.

Br J Haematol. 2015 Jun;169(5):760-1. doi: 10.1111/bjh.13249. Epub 2015 Jan 8. No abstract available.

PMID:
25573033
44.

Ultra-thin strut cobalt chromium bare metal stent usage in a complex real-world setting. (SOLSTICE registry).

Suttorp MJ, Stella PR, Dens J, McKenzie JM, Park KS, Frambach P; SOLSTICE investigators.

Neth Heart J. 2015 Feb;23(2):124-9. doi: 10.1007/s12471-014-0629-6.

45.

Osteosarcoma in patients with Rothmund-Thomson syndrome.

Zils K, Klingebiel T, Behnisch W, Mueller HL, Schlegel PG, Fruehwald M, Suttorp M, Simon T, Werner M, Bielack S.

Pediatr Hematol Oncol. 2015 Feb;32(1):32-40. doi: 10.3109/08880018.2014.987939. Epub 2014 Dec 31.

PMID:
25551679
46.

Inhibitory effects of imatinib on vitamin D₃ synthesis in human keratinocytes.

Mehlig LM, Garve C, Tauer JT, Suttorp M, Bauer A.

Mol Med Rep. 2015 Apr;11(4):3143-7. doi: 10.3892/mmr.2014.3074. Epub 2014 Dec 10.

PMID:
25501030
47.

Chronic myeloid leukemia in children: clinical findings, management, and unanswered questions.

Hijiya N, Millot F, Suttorp M.

Pediatr Clin North Am. 2015 Feb;62(1):107-19. doi: 10.1016/j.pcl.2014.09.008. Review.

PMID:
25435115
48.

Graphical presentation of confounding in directed acyclic graphs.

Suttorp MM, Siegerink B, Jager KJ, Zoccali C, Dekker FW.

Nephrol Dial Transplant. 2015 Sep;30(9):1418-23. doi: 10.1093/ndt/gfu325. Epub 2014 Oct 16. Review.

PMID:
25324358
49.

Erythropoiesis-stimulating agents and thrombotic events in dialysis patients.

Suttorp MM, Hoekstra T, Ocak G, van Diepen AT, Ott I, Mittelman M, Rabelink TJ, Krediet RT, Dekker FW.

Thromb Res. 2014 Nov;134(5):1081-6. doi: 10.1016/j.thromres.2014.07.030. Epub 2014 Aug 1.

PMID:
25242244
50.

The influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMI.

Demetz G, Laux M, Scherhag A, Hoekstra T, Suttorp MM, Dekker F, Roest M, Marcus-Kalish M, Mittelman M, Ott I.

Thromb J. 2014 Aug 28;12:18. doi: 10.1186/1477-9560-12-18. eCollection 2014.

Supplemental Content

Loading ...
Support Center